The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome
Background. Polycystic ovary syndrome (PCOS) and hypothyroidism are the most common endocrinological disorders among women of reproductive age. Since hypothyroidism occurs more frequently in PCOS patients, it is vital to explain its clinical impact. Aim. To evaluate the impact of subclinical hypothy...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2021/8427150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832557100953239552 |
|---|---|
| author | Karolina Kowalczyk Patrycja Radosz Kamil Barański Dagmara Pluta Dariusz Kowalczyk Grzegorz Franik Paweł Madej |
| author_facet | Karolina Kowalczyk Patrycja Radosz Kamil Barański Dagmara Pluta Dariusz Kowalczyk Grzegorz Franik Paweł Madej |
| author_sort | Karolina Kowalczyk |
| collection | DOAJ |
| description | Background. Polycystic ovary syndrome (PCOS) and hypothyroidism are the most common endocrinological disorders among women of reproductive age. Since hypothyroidism occurs more frequently in PCOS patients, it is vital to explain its clinical impact. Aim. To evaluate the impact of subclinical hypothyroidism (SCH) and its treatment on the metabolic profile of patients with PCOS. Methods. 190 women with PCOS phenotype A were enrolled in the case-control study. They were divided into three groups: 38 women with PCOS and subclinical hypothyroidism, 76 women with PCOS and SCH under thyroid replacement therapy, and 76 women with PCOS and normal thyroid function (control group). Serum lipids, fasting glucose, and insulin, as well as oral glucose tolerance tests were performed. Results. In the analyzed parameters, there were no statistic differences between the groups in relation to thyroid function. BMI turned out to be the main factor dividing the patients in terms of serum lipids, fasting glucose, fasting insulin, and oral glucose tolerance test. TSH was associated with total cholesterol and LDL cholesterol levels, whereas BMI has a dominant impact on HDL cholesterol, triglycerides, glucose, and insulin resistance. Conclusions. SCH is associated with mild lipid serum alterations in women with PCOS, but it is BMI to have a dominant impact on glucose and insulin. It seems that treatment of SCH in PCOS does not significantly alter lipid and glucose metabolism. |
| format | Article |
| id | doaj-art-6c942b1f53ab4f25a8ef4affd756e530 |
| institution | Kabale University |
| issn | 1687-8345 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-6c942b1f53ab4f25a8ef4affd756e5302025-02-03T05:43:35ZengWileyInternational Journal of Endocrinology1687-83452021-01-01202110.1155/2021/8427150The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary SyndromeKarolina Kowalczyk0Patrycja Radosz1Kamil Barański2Dagmara Pluta3Dariusz Kowalczyk4Grzegorz Franik5Paweł Madej6Department of Endocrinological GynaecologyDepartment of Endocrinological GynaecologyDepartment of EpidemiologyDepartment of Endocrinological GynaecologyDepartment of AnatomyDepartment of Endocrinological GynaecologyDepartment of Endocrinological GynaecologyBackground. Polycystic ovary syndrome (PCOS) and hypothyroidism are the most common endocrinological disorders among women of reproductive age. Since hypothyroidism occurs more frequently in PCOS patients, it is vital to explain its clinical impact. Aim. To evaluate the impact of subclinical hypothyroidism (SCH) and its treatment on the metabolic profile of patients with PCOS. Methods. 190 women with PCOS phenotype A were enrolled in the case-control study. They were divided into three groups: 38 women with PCOS and subclinical hypothyroidism, 76 women with PCOS and SCH under thyroid replacement therapy, and 76 women with PCOS and normal thyroid function (control group). Serum lipids, fasting glucose, and insulin, as well as oral glucose tolerance tests were performed. Results. In the analyzed parameters, there were no statistic differences between the groups in relation to thyroid function. BMI turned out to be the main factor dividing the patients in terms of serum lipids, fasting glucose, fasting insulin, and oral glucose tolerance test. TSH was associated with total cholesterol and LDL cholesterol levels, whereas BMI has a dominant impact on HDL cholesterol, triglycerides, glucose, and insulin resistance. Conclusions. SCH is associated with mild lipid serum alterations in women with PCOS, but it is BMI to have a dominant impact on glucose and insulin. It seems that treatment of SCH in PCOS does not significantly alter lipid and glucose metabolism.http://dx.doi.org/10.1155/2021/8427150 |
| spellingShingle | Karolina Kowalczyk Patrycja Radosz Kamil Barański Dagmara Pluta Dariusz Kowalczyk Grzegorz Franik Paweł Madej The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome International Journal of Endocrinology |
| title | The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome |
| title_full | The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome |
| title_fullStr | The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome |
| title_full_unstemmed | The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome |
| title_short | The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome |
| title_sort | influence of treated and untreated subclinical hypothyroidism on metabolic profile in women with polycystic ovary syndrome |
| url | http://dx.doi.org/10.1155/2021/8427150 |
| work_keys_str_mv | AT karolinakowalczyk theinfluenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT patrycjaradosz theinfluenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT kamilbaranski theinfluenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT dagmarapluta theinfluenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT dariuszkowalczyk theinfluenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT grzegorzfranik theinfluenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT pawełmadej theinfluenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT karolinakowalczyk influenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT patrycjaradosz influenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT kamilbaranski influenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT dagmarapluta influenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT dariuszkowalczyk influenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT grzegorzfranik influenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome AT pawełmadej influenceoftreatedanduntreatedsubclinicalhypothyroidismonmetabolicprofileinwomenwithpolycysticovarysyndrome |